SUVENPHAR.NSE Suven Pharmaceuticals Ltd.
51
613.95
16.55
(2.63%)
| Watchers | 51 |
| 52-Wk Low | 469.45 |
| 52-Wk High | 768.00 |
| Market Cap | 157.14B |
| Volume | 903,867.00 |
| 52-Wk High | 768.00 |
| 52-Wk Low | 469.45 |
Stock Radar: Apollo Hospitals, Bharat Dynamics, Muthoot Finance, BGR Energy, Tube Investments in focus on FridayMoneycontrol • 3 days ago
Sun Pharma accepted preferential offer to acquire 14.28% shares of Indian Foundation for Quality Management, while Jio Financial Services launched JioFinance App in a Beta version.
Share to Feed
In September 2023, the US-based private equity firm Advent acquired a controlling stake in Suven, expressing the intent to create a billion-dollar platform in the CDMO space.
Foreign investor Apis Growth 6 sold 1.7 percent stake in Star Health and Allied Insurance
The overall transaction is expected to conclude over the next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals.
Suven Pharma reported a sharp decline in its net profit, revenue and profitability in Q3.
The pharma company expects that the next few quarters to continue to be soft due to the impact of global destocking in specialty chemicals and FY23 base effect
According to the report, India hosted 22 in 2023 for a deal value of $4.6 billion. In 2022, the deal value was $4.7 billion.